Lecture 1 - Drugs & Therapeutics
Pharmacology: A science that studies drugs and their actions on living systems.
Drug Definition: A chemical with a selective therapeutic action, described as a "magic bullet" targeting specific physiological pathways.
Key Features of a Drug:
Chemical Structure: Defined molecular composition (e.g., Caffeine).
Physiological Response: Specific effects on the body (e.g., CNS stimulant from Caffeine).
Physiological Targets: Interaction with specific biological structures (e.g., Adenosine receptors).
Page 6: Historical Context of Pharmacology
Pioneered by: Paul Ehrlich - conceptualized 'magic bullets' for disease targeting.
Importance: Understanding pharmacology is critical for designing specific drugs and minimizing side effects.
Page 7: Integral Branches of Pharmacology
Pharmacodynamics (PD)
Focus: What the drug does to the body, including:
Drug action
Mechanisms of drug effects at the molecular or cellular levels.
Pharmacokinetics (PK)
Focus: What the body does to the drug, involving processes such as:
Absorption: Drug entry into the bloodstream.
Distribution: Drug transport within the body.
Metabolism: Drug breakdown (often in the liver).
Excretion: Drug elimination (primarily via kidneys).
Interdependence of PD and PK:
PK determines drug concentration at the action site.
PD determines therapeutic and side effects.
Page 8: Clinical Relevance of PD and PK
Understanding these principles optimizes drug dosing, efficacy, and patient safety.
Page 9: Specificity in Pharmacology
Biological Specificity
Definition: "Right target" for a drug to elicit a specific physiological response.
Example: Adrenaline acting on adrenergic receptors leads to increased heart rate and muscle contraction.
Key Concept of Specificity
Chemical Specificity: The ability of a drug to bind correctly to intended binding sites.
Page 10: Therapeutic Uses of Adrenaline
Adrenaline’s actions on β-receptors:
β1 Receptors: Increases heart rate, enhances cardiac muscle contraction.
β2 Receptors: Relaxes airway smooth muscles, aiding respiration during stress or exercise.
Page 11: Chemical Specificity
Adrenaline binds selectively to adrenergic β-receptors, illustrating drug-receptor interaction and specificity of drug action.
Page 12: Lock and Key System
Key Takeaway:
Chemical specificity allows drugs to fit into binding sites, activating intended physiological pathways while minimizing side effects.
Page 13: Key Drug Binding Sites
Types of Targets:
Enzymes
Transporters
Ion Channels
Receptors
Page 14: Receptor Classification
Types of Receptors:
Ligand-gated Ion Channels: Direct ion flow upon activation.
G-Protein-Coupled Receptors (GPCRs): Mediate signal transduction through G-proteins.
Catalytic Receptors: Trigger intracellular signaling cascades.
Nuclear Receptors: Regulate gene expression.
Page 15: Drug Interactions with Enzymes
Enzyme Inhibition Examples
Phosphodiesterase: Drug - Sildenafil increases vasodilation.
Acetylcholine Esterase: Drug - Neostigmine increases acetylcholine availability.
Cyclooxygenase: Inhibitors like Ibuprofen and Aspirin reduce inflammation.
Page 16: Enzyme Substrate Interaction
L-DOPA: Acts as a precursor for dopamine synthesis, aiding motor symptoms in Parkinson’s disease.
Page 17: Drug-Targeting Mechanisms
Binding Mechanisms
Non-Competitive Binding:
Aspirin inhibits COX by binding a different site.
Competitive Binding:
Neostigmine competes with acetylcholine for binding to acetylcholinesterase.
Page 18: Efficacy in Drug Design
Key Distinction:
Non-competitive inhibitors affect function irrespective of substrate concentration.
Competitive inhibitors depend on drug concentration relative to the natural substrate.
Page 19: Transporter Targeting
Case Study: Noradrenaline Transporter:
Normal function vs how Cocaine blocks the na uptake, increasing synaptic NA levels causing amplified responses.
Page 20: Voltage-Gated Ion Channels
Example: Lidocaine blocks sodium channels in depolarized states, used as a local anaesthetic.
Page 21: Receptors as Drug Targets
Receptor Types:
Nuclear, ligand gated, catalytic, and G-protein coupled receptors initiate cellular responses through endogenous messengers.
Page 22: G-Protein Coupled Receptors (GPCRs)
Role as Drug Targets:
Initiate downstream signaling upon ligand binding, leading to physiological responses.
Page 23: Characteristics of Receptors
Key Concepts:
Receptor States: Inactive and active states influenced by ligand binding.
Ligand Selectivity: Specific binding to cause activation.
Molecular Switch Mechanism: Transition from inactive to active state upon ligand binding initiates signaling.
Page 24: Amplification Mechanism
Signal Amplification: Receptors amplify signals leading to larger cellular responses, crucial in low-ligand scenarios.
Page 25: General Characteristics of Receptors
Illustrates how receptors mediate signals for cellular responses through amplification techniques.
Page 26: Outcomes of Signal Amplification
Outcome: Strong cellular responses are achieved through mechanisms like ion flow and messenger synthesis.
Page 27: Drug Response Specificity
Biological and Chemical Specificity:
Critical for drug action, influenced by pharmacokinetics (ADME processes).
Page 28: Drug Development Implications
Understanding specificity helps improve drug efficacy and reduce side effects in pharmacokinetics.
Page 29: Relativity in Pharmacology
Claude Bernard's Quote: “Tout est poison, rien n'est poison, tout est une question de dose” (Everything is poisonous, nothing is poisonous, it's all a matter of dose).
Page 30: Importance in Clinical Practice
Understanding specificity and dose-dependence ensures tailored treatments and drug safety.
Page 31: Risk-Benefit Assessment in Drug Development
Importance of assessing risk over potential benefits in pharmaceutical development, illustrated by historical case studies.
Page 32: Continuous Monitoring
Highlighted by cases such as Thalidomide and Aspirin, market authorization includes balancing therapeutic action vs. adverse effects.
Page 33: Summary of Pharmacology Understanding
Key Points:
The study of drugs involves understanding specificity, action, and risk assessment.
The relationship between drug concentration, therapeutic effects, and side effects is crucial in pharmacological studies.